PEOPLE - CardioDynamics' makes appointment:
This article was originally published in Clinica
Executive Summary
Jay Warren has joined San Diego, California-based CardioDynamics' board of directors. Mr Warren has worked for several leading medtech companies, including Guidant (vice-president, R&D), Medtronic and Intermedics, and is currently the president and CEO of Cameron Health (subcutaneous implantable defibrillator systems). CardioDynamics develops and manufactures non-invasive diagnostic and monitoring technologies and electrodes.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.